Loading...

Treatment of Concurrent Minimal Change Disease and Epstein Barr Virus–Driven Post-transplant Lymphoproliferative Disorder With Rituximab Following Hematopoietic Stem Cell Transplantation

Saved in:
Bibliographic Details
Published in:Kidney Int Rep
Main Authors: Ainley, Louise, Law, Steven, Heptinstall, Lauren, Rodriguez-Justo, Manuel, Thomson, Kirsty, Pepper, Ruth J.
Format: Artigo
Language:Inglês
Published: Elsevier 2020
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7783564/
https://ncbi.nlm.nih.gov/pubmed/33426402
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ekir.2020.10.012
Tags: Add Tag
No Tags, Be the first to tag this record!